APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fungal Drugs for Treatment of Tinea

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fungal Drugs for Treatment of Tinea Market Analysis and Forecast 2026-2032

Report ID 173993490221 December 2025213 pages

Choose your research edition.

Industry ResearchFungal Drugs for Treatment of Tinea Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Fungal Drugs for Treatment of Tinea Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Fungal Drugs for Treatment of Tinea Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fungal Drugs for Treatment of Tinea Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Fungal Drugs for Treatment of Tinea Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Fungal Drugs for Treatment of Tinea market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Fungal Drugs for Treatment of Tinea is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fungal Drugs for Treatment of Tinea is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fungal Drugs for Treatment of Tinea is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fungal Drugs for Treatment of Tinea is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Fungal Drugs for Treatment of Tinea include Tianjin Lisheng Pharmaceuticals, Teva Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Shandong Qilu Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Shandong Jingwei Pharmaceutical, Sandoz, Johnson & Johnson and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Fungal Drugs for Treatment of Tinea, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fungal Drugs for Treatment of Tinea, also provides the revenue of main regions and countries. Of the upcoming market potential for Fungal Drugs for Treatment of Tinea, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fungal Drugs for Treatment of Tinea revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fungal Drugs for Treatment of Tinea market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fungal Drugs for Treatment of Tinea revenue, projected growth trends, production technology, application and end-user industry.

Fungal Drugs for Treatment of Tinea Segment by Company

Tianjin Lisheng Pharmaceuticals

Teva Pharmaceuticals

Shanghai Modern Hasen (Shangqiu) Pharmaceuticals

Shandong Qilu Pharmaceuticals

Shandong Luoxin Pharmaceuticals

Shandong Jingwei Pharmaceutical

Sandoz

Johnson & Johnson

Novartis

Jiangsu Zhiyuan Pharmaceutical

Jiangsu Yunyang Group Pharmaceuticals

Hubei Hengan Fulin

Hainan Kangzhi Pharmaceuticals

Harbin Sanlian Pharmaceuticals

Guilin Huaxin Pharmaceuticals

GSK

Chengdu Beite Pharmaceuticals

Bayer

Ultratech India

Perrigo

Padagis

Kaken Pharmaceutical

Gufic Biosciences

Galderma

Bausch Health

Fungal Drugs for Treatment of Tinea Segment by Type

Topical Drugs

Oral Drugs

Fungal Drugs for Treatment of Tinea Segment by Application

Hospital Pharmacy

Online

Retail Pharmacy

Fungal Drugs for Treatment of Tinea Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Drugs for Treatment of Tinea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fungal Drugs for Treatment of Tinea and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Drugs for Treatment of Tinea.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Fungal Drugs for Treatment of Tinea in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Fungal Drugs for Treatment of Tinea company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fungal Drugs for Treatment of Tinea revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Topical Drugs Major Player Table 3. Oral Drugs Major Player Table 4. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacy Major Player Table 6. Online Major Player Table 7. Retail Pharmacy Major Player Table 8. Fungal Drugs for Treatment of Tinea Industry Trends Table 9. Fungal Drugs for Treatment of Tinea Industry Drivers Table 10. Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges Table 11. Fungal Drugs for Treatment of Tinea Industry Restraints Table 12. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2021-2026) Table 15. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2027-2032) Table 17. Global Fungal Drugs for Treatment of Tinea Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Players (2021-2026) Table 19. Global Fungal Drugs for Treatment of Tinea Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Fungal Drugs for Treatment of Tinea Key Players Headquarters & Area Served Table 21. Global Fungal Drugs for Treatment of Tinea Players, Product Type & Application Table 22. Global Fungal Drugs for Treatment of Tinea Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Fungal Drugs for Treatment of Tinea by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Fungal Drugs for Treatment of Tinea Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2021-2026) Table 29. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2027-2032) Table 30. Global Fungal Drugs for Treatment of Tinea Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2021-2026) Table 34. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2027-2032) Table 35. Tianjin Lisheng Pharmaceuticals Company Information Table 36. Tianjin Lisheng Pharmaceuticals Business Overview Table 37. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 39. Tianjin Lisheng Pharmaceuticals Recent Development Table 40. Teva Pharmaceuticals Company Information Table 41. Teva Pharmaceuticals Business Overview Table 42. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 44. Teva Pharmaceuticals Recent Development Table 45. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information Table 46. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview Table 47. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 49. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Development Table 50. Shandong Qilu Pharmaceuticals Company Information Table 51. Shandong Qilu Pharmaceuticals Business Overview Table 52. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 54. Shandong Qilu Pharmaceuticals Recent Development Table 55. Shandong Luoxin Pharmaceuticals Company Information Table 56. Shandong Luoxin Pharmaceuticals Business Overview Table 57. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 59. Shandong Luoxin Pharmaceuticals Recent Development Table 60. Shandong Jingwei Pharmaceutical Company Information Table 61. Shandong Jingwei Pharmaceutical Business Overview Table 62. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 64. Shandong Jingwei Pharmaceutical Recent Development Table 65. Sandoz Company Information Table 66. Sandoz Business Overview Table 67. Sandoz Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio Table 69. Sandoz Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Novartis Fungal Drugs for Treatment of Tinea Product Portfolio Table 79. Novartis Recent Development Table 80. Jiangsu Zhiyuan Pharmaceutical Company Information Table 81. Jiangsu Zhiyuan Pharmaceutical Business Overview Table 82. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 84. Jiangsu Zhiyuan Pharmaceutical Recent Development Table 85. Jiangsu Yunyang Group Pharmaceuticals Company Information Table 86. Jiangsu Yunyang Group Pharmaceuticals Business Overview Table 87. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 89. Jiangsu Yunyang Group Pharmaceuticals Recent Development Table 90. Hubei Hengan Fulin Company Information Table 91. Hubei Hengan Fulin Business Overview Table 92. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio Table 94. Hubei Hengan Fulin Recent Development Table 95. Hainan Kangzhi Pharmaceuticals Company Information Table 96. Hainan Kangzhi Pharmaceuticals Business Overview Table 97. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 99. Hainan Kangzhi Pharmaceuticals Recent Development Table 100. Harbin Sanlian Pharmaceuticals Company Information Table 101. Harbin Sanlian Pharmaceuticals Business Overview Table 102. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 104. Harbin Sanlian Pharmaceuticals Recent Development Table 105. Guilin Huaxin Pharmaceuticals Company Information Table 106. Guilin Huaxin Pharmaceuticals Business Overview Table 107. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 109. Guilin Huaxin Pharmaceuticals Recent Development Table 110. GSK Company Information Table 111. GSK Business Overview Table 112. GSK Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. GSK Fungal Drugs for Treatment of Tinea Product Portfolio Table 114. GSK Recent Development Table 115. Chengdu Beite Pharmaceuticals Company Information Table 116. Chengdu Beite Pharmaceuticals Business Overview Table 117. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 119. Chengdu Beite Pharmaceuticals Recent Development Table 120. Bayer Company Information Table 121. Bayer Business Overview Table 122. Bayer Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Bayer Fungal Drugs for Treatment of Tinea Product Portfolio Table 124. Bayer Recent Development Table 125. Ultratech India Company Information Table 126. Ultratech India Business Overview Table 127. Ultratech India Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio Table 129. Ultratech India Recent Development Table 130. Perrigo Company Information Table 131. Perrigo Business Overview Table 132. Perrigo Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio Table 134. Perrigo Recent Development Table 135. Padagis Company Information Table 136. Padagis Business Overview Table 137. Padagis Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Padagis Fungal Drugs for Treatment of Tinea Product Portfolio Table 139. Padagis Recent Development Table 140. Kaken Pharmaceutical Company Information Table 141. Kaken Pharmaceutical Business Overview Table 142. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 144. Kaken Pharmaceutical Recent Development Table 145. Gufic Biosciences Company Information Table 146. Gufic Biosciences Business Overview Table 147. Gufic Biosciences Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio Table 149. Gufic Biosciences Recent Development Table 150. Galderma Company Information Table 151. Galderma Business Overview Table 152. Galderma Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Galderma Fungal Drugs for Treatment of Tinea Product Portfolio Table 154. Galderma Recent Development Table 155. Bausch Health Company Information Table 156. Bausch Health Business Overview Table 157. Bausch Health Fungal Drugs for Treatment of Tinea Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 158. Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio Table 159. Bausch Health Recent Development Table 160. North America Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 161. North America Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 162. North America Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 163. North America Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 164. North America Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. North America Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026) & (US$ Million) Table 166. North America Fungal Drugs for Treatment of Tinea Revenue by Country (US$ Million) & (2027-2032) Table 167. Europe Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 168. Europe Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 169. Europe Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 170. Europe Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 171. Europe Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Europe Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026) & (US$ Million) Table 173. Europe Fungal Drugs for Treatment of Tinea Revenue by Country (US$ Million) & (2027-2032) Table 174. China Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 175. China Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 176. China Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 177. China Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Fungal Drugs for Treatment of Tinea Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Fungal Drugs for Treatment of Tinea Revenue by Region (US$ Million) & (2021-2026) Table 184. Asia Fungal Drugs for Treatment of Tinea Revenue by Region (US$ Million) & (2027-2032) Table 185. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026) & (US$ Million) Table 188. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032) & (US$ Million) Table 189. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026) & (US$ Million) Table 191. SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (US$ Million) & (2027-2032) Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Fungal Drugs for Treatment of Tinea Image Figure 2. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fungal Drugs for Treatment of Tinea Market Size Share 2021 VS 2025 VS 2032 Figure 4. Topical Drugs Image Figure 5. Oral Drugs Image Figure 6. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Fungal Drugs for Treatment of Tinea Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Online Image Figure 10. Retail Pharmacy Image Figure 11. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million) & (2021-2032) Figure 12. Global Fungal Drugs for Treatment of Tinea Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Fungal Drugs for Treatment of Tinea Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Fungal Drugs for Treatment of Tinea Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Fungal Drugs for Treatment of Tinea Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Fungal Drugs for Treatment of Tinea Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2021-2032) Figure 19. Global Fungal Drugs for Treatment of Tinea Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2021-2032) Figure 22. North America Fungal Drugs for Treatment of Tinea Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032) Figure 24. North America Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032) Figure 25. North America Fungal Drugs for Treatment of Tinea Revenue Share by Country (2021-2032) Figure 26. United States Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Fungal Drugs for Treatment of Tinea Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032) Figure 31. Europe Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032) Figure 32. Europe Fungal Drugs for Treatment of Tinea Revenue Share by Country (2021-2032) Figure 33. Germany Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Fungal Drugs for Treatment of Tinea Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032) Figure 43. China Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032) Figure 44. Asia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032) Figure 46. Asia Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032) Figure 47. Asia Fungal Drugs for Treatment of Tinea Revenue Share by Region (2021-2032) Figure 48. Japan Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Fungal Drugs for Treatment of Tinea Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032) Figure 56. SAMEA Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032) Figure 57. SAMEA Fungal Drugs for Treatment of Tinea Revenue Share by Country (2021-2032) Figure 58. Brazil Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Fungal Drugs for Treatment of Tinea Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Drugs
  • Oral Drugs
Applications
  • Hospital Pharmacy
  • Online
  • Retail Pharmacy
Companies covered
  • Tianjin Lisheng Pharmaceuticals
  • Teva Pharmaceuticals
  • Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  • Shandong Qilu Pharmaceuticals
  • Shandong Luoxin Pharmaceuticals
  • Shandong Jingwei Pharmaceutical
  • Sandoz
  • Johnson & Johnson
  • Novartis
  • Jiangsu Zhiyuan Pharmaceutical
  • Jiangsu Yunyang Group Pharmaceuticals
  • Hubei Hengan Fulin
  • Hainan Kangzhi Pharmaceuticals
  • Harbin Sanlian Pharmaceuticals
  • Guilin Huaxin Pharmaceuticals
  • GSK
  • Chengdu Beite Pharmaceuticals
  • Bayer
  • Ultratech India
  • Perrigo
  • Padagis
  • Kaken Pharmaceutical
  • Gufic Biosciences
  • Galderma
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fungal Drugs for Treatment of Tinea Market by Type
  3. 1.2.1 Global Fungal Drugs for Treatment of Tinea Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Topical Drugs
  5. 1.2.3 Oral Drugs
  6. 1.3 Fungal Drugs for Treatment of Tinea Market by Application
  7. 1.3.1 Global Fungal Drugs for Treatment of Tinea Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Online
  10. 1.3.4 Retail Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Fungal Drugs for Treatment of Tinea Market Dynamics
  1. 2.1 Fungal Drugs for Treatment of Tinea Industry Trends
  2. 2.2 Fungal Drugs for Treatment of Tinea Industry Drivers
  3. 2.3 Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges
  4. 2.4 Fungal Drugs for Treatment of Tinea Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Fungal Drugs for Treatment of Tinea Market Perspective (2021-2032)
  2. 3.2 Global Fungal Drugs for Treatment of Tinea Growth Trends by Region
  3. 3.2.1 Global Fungal Drugs for Treatment of Tinea Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026)
  5. 3.2.3 Global Fungal Drugs for Treatment of Tinea Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Fungal Drugs for Treatment of Tinea Revenue by Players
  2. 4.1.1 Global Fungal Drugs for Treatment of Tinea Revenue by Players (2021-2026)
  3. 4.1.2 Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Fungal Drugs for Treatment of Tinea Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fungal Drugs for Treatment of Tinea Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Fungal Drugs for Treatment of Tinea Key Players Headquarters & Area Served
  7. 4.4 Global Fungal Drugs for Treatment of Tinea Players, Product Type & Application
  8. 4.5 Global Fungal Drugs for Treatment of Tinea Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Fungal Drugs for Treatment of Tinea Market CR5 and HHI
  11. 4.6.3 2025 Fungal Drugs for Treatment of Tinea Tier 1, Tier 2, and Tier 3
5 Fungal Drugs for Treatment of Tinea Market Size by Type
  1. 5.1 Global Fungal Drugs for Treatment of Tinea Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 5.3 Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2021-2032)
6 Fungal Drugs for Treatment of Tinea Market Size by Application
  1. 6.1 Global Fungal Drugs for Treatment of Tinea Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  3. 6.3 Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Tianjin Lisheng Pharmaceuticals
  2. 7.1.1 Tianjin Lisheng Pharmaceuticals Company Information
  3. 7.1.2 Tianjin Lisheng Pharmaceuticals Business Overview
  4. 7.1.3 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  6. 7.1.5 Tianjin Lisheng Pharmaceuticals Recent Developments
  7. 7.2 Teva Pharmaceuticals
  8. 7.2.1 Teva Pharmaceuticals Company Information
  9. 7.2.2 Teva Pharmaceuticals Business Overview
  10. 7.2.3 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  12. 7.2.5 Teva Pharmaceuticals Recent Developments
  13. 7.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  14. 7.3.1 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information
  15. 7.3.2 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
  16. 7.3.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  18. 7.3.5 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Developments
  19. 7.4 Shandong Qilu Pharmaceuticals
  20. 7.4.1 Shandong Qilu Pharmaceuticals Company Information
  21. 7.4.2 Shandong Qilu Pharmaceuticals Business Overview
  22. 7.4.3 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  24. 7.4.5 Shandong Qilu Pharmaceuticals Recent Developments
  25. 7.5 Shandong Luoxin Pharmaceuticals
  26. 7.5.1 Shandong Luoxin Pharmaceuticals Company Information
  27. 7.5.2 Shandong Luoxin Pharmaceuticals Business Overview
  28. 7.5.3 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  30. 7.5.5 Shandong Luoxin Pharmaceuticals Recent Developments
  31. 7.6 Shandong Jingwei Pharmaceutical
  32. 7.6.1 Shandong Jingwei Pharmaceutical Company Information
  33. 7.6.2 Shandong Jingwei Pharmaceutical Business Overview
  34. 7.6.3 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  36. 7.6.5 Shandong Jingwei Pharmaceutical Recent Developments
  37. 7.7 Sandoz
  38. 7.7.1 Sandoz Company Information
  39. 7.7.2 Sandoz Business Overview
  40. 7.7.3 Sandoz Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio
  42. 7.7.5 Sandoz Recent Developments
  43. 7.8 Johnson & Johnson
  44. 7.8.1 Johnson & Johnson Company Information
  45. 7.8.2 Johnson & Johnson Business Overview
  46. 7.8.3 Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio
  48. 7.8.5 Johnson & Johnson Recent Developments
  49. 7.9 Novartis
  50. 7.9.1 Novartis Company Information
  51. 7.9.2 Novartis Business Overview
  52. 7.9.3 Novartis Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novartis Fungal Drugs for Treatment of Tinea Product Portfolio
  54. 7.9.5 Novartis Recent Developments
  55. 7.10 Jiangsu Zhiyuan Pharmaceutical
  56. 7.10.1 Jiangsu Zhiyuan Pharmaceutical Company Information
  57. 7.10.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
  58. 7.10.3 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  60. 7.10.5 Jiangsu Zhiyuan Pharmaceutical Recent Developments
  61. 7.11 Jiangsu Yunyang Group Pharmaceuticals
  62. 7.11.1 Jiangsu Yunyang Group Pharmaceuticals Company Information
  63. 7.11.2 Jiangsu Yunyang Group Pharmaceuticals Business Overview
  64. 7.11.3 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  66. 7.11.5 Jiangsu Yunyang Group Pharmaceuticals Recent Developments
  67. 7.12 Hubei Hengan Fulin
  68. 7.12.1 Hubei Hengan Fulin Company Information
  69. 7.12.2 Hubei Hengan Fulin Business Overview
  70. 7.12.3 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio
  72. 7.12.5 Hubei Hengan Fulin Recent Developments
  73. 7.13 Hainan Kangzhi Pharmaceuticals
  74. 7.13.1 Hainan Kangzhi Pharmaceuticals Company Information
  75. 7.13.2 Hainan Kangzhi Pharmaceuticals Business Overview
  76. 7.13.3 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  78. 7.13.5 Hainan Kangzhi Pharmaceuticals Recent Developments
  79. 7.14 Harbin Sanlian Pharmaceuticals
  80. 7.14.1 Harbin Sanlian Pharmaceuticals Company Information
  81. 7.14.2 Harbin Sanlian Pharmaceuticals Business Overview
  82. 7.14.3 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  84. 7.14.5 Harbin Sanlian Pharmaceuticals Recent Developments
  85. 7.15 Guilin Huaxin Pharmaceuticals
  86. 7.15.1 Guilin Huaxin Pharmaceuticals Company Information
  87. 7.15.2 Guilin Huaxin Pharmaceuticals Business Overview
  88. 7.15.3 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  90. 7.15.5 Guilin Huaxin Pharmaceuticals Recent Developments
  91. 7.16 GSK
  92. 7.16.1 GSK Company Information
  93. 7.16.2 GSK Business Overview
  94. 7.16.3 GSK Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  95. 7.16.4 GSK Fungal Drugs for Treatment of Tinea Product Portfolio
  96. 7.16.5 GSK Recent Developments
  97. 7.17 Chengdu Beite Pharmaceuticals
  98. 7.17.1 Chengdu Beite Pharmaceuticals Company Information
  99. 7.17.2 Chengdu Beite Pharmaceuticals Business Overview
  100. 7.17.3 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  102. 7.17.5 Chengdu Beite Pharmaceuticals Recent Developments
  103. 7.18 Bayer
  104. 7.18.1 Bayer Company Information
  105. 7.18.2 Bayer Business Overview
  106. 7.18.3 Bayer Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Bayer Fungal Drugs for Treatment of Tinea Product Portfolio
  108. 7.18.5 Bayer Recent Developments
  109. 7.19 Ultratech India
  110. 7.19.1 Ultratech India Company Information
  111. 7.19.2 Ultratech India Business Overview
  112. 7.19.3 Ultratech India Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio
  114. 7.19.5 Ultratech India Recent Developments
  115. 7.20 Perrigo
  116. 7.20.1 Perrigo Company Information
  117. 7.20.2 Perrigo Business Overview
  118. 7.20.3 Perrigo Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio
  120. 7.20.5 Perrigo Recent Developments
  121. 7.21 Padagis
  122. 7.21.1 Padagis Company Information
  123. 7.21.2 Padagis Business Overview
  124. 7.21.3 Padagis Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Padagis Fungal Drugs for Treatment of Tinea Product Portfolio
  126. 7.21.5 Padagis Recent Developments
  127. 7.22 Kaken Pharmaceutical
  128. 7.22.1 Kaken Pharmaceutical Company Information
  129. 7.22.2 Kaken Pharmaceutical Business Overview
  130. 7.22.3 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  132. 7.22.5 Kaken Pharmaceutical Recent Developments
  133. 7.23 Gufic Biosciences
  134. 7.23.1 Gufic Biosciences Company Information
  135. 7.23.2 Gufic Biosciences Business Overview
  136. 7.23.3 Gufic Biosciences Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio
  138. 7.23.5 Gufic Biosciences Recent Developments
  139. 7.24 Galderma
  140. 7.24.1 Galderma Company Information
  141. 7.24.2 Galderma Business Overview
  142. 7.24.3 Galderma Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Galderma Fungal Drugs for Treatment of Tinea Product Portfolio
  144. 7.24.5 Galderma Recent Developments
  145. 7.25 Bausch Health
  146. 7.25.1 Bausch Health Company Information
  147. 7.25.2 Bausch Health Business Overview
  148. 7.25.3 Bausch Health Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio
  150. 7.25.5 Bausch Health Recent Developments
8 North America
  1. 8.1 North America Fungal Drugs for Treatment of Tinea Revenue (2021-2032)
  2. 8.2 North America Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 8.2.1 North America Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026)
  4. 8.2.2 North America Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032)
  5. 8.3 North America Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032)
  6. 8.4 North America Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  7. 8.4.1 North America Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026)
  8. 8.4.2 North America Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032)
  9. 8.5 North America Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032)
  10. 8.6 North America Fungal Drugs for Treatment of Tinea Revenue by Country
  11. 8.6.1 North America Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026)
  13. 8.6.3 North America Fungal Drugs for Treatment of Tinea Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Fungal Drugs for Treatment of Tinea Revenue (2021-2032)
  2. 9.2 Europe Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 9.2.1 Europe Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026)
  4. 9.2.2 Europe Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032)
  5. 9.3 Europe Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032)
  6. 9.4 Europe Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  7. 9.4.1 Europe Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026)
  8. 9.4.2 Europe Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032)
  9. 9.5 Europe Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032)
  10. 9.6 Europe Fungal Drugs for Treatment of Tinea Revenue by Country
  11. 9.6.1 Europe Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026)
  13. 9.6.3 Europe Fungal Drugs for Treatment of Tinea Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Fungal Drugs for Treatment of Tinea Revenue (2021-2032)
  2. 10.2 China Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 10.2.1 China Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026)
  4. 10.2.2 China Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032)
  5. 10.3 China Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032)
  6. 10.4 China Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  7. 10.4.1 China Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026)
  8. 10.4.2 China Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032)
  9. 10.5 China Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fungal Drugs for Treatment of Tinea Revenue (2021-2032)
  2. 11.2 Asia Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 11.2.1 Asia Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026)
  4. 11.2.2 Asia Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032)
  5. 11.3 Asia Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032)
  6. 11.4 Asia Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  7. 11.4.1 Asia Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026)
  8. 11.4.2 Asia Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032)
  9. 11.5 Asia Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032)
  10. 11.6 Asia Fungal Drugs for Treatment of Tinea Revenue by Country
  11. 11.6.1 Asia Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026)
  13. 11.6.3 Asia Fungal Drugs for Treatment of Tinea Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fungal Drugs for Treatment of Tinea Revenue (2021-2032)
  2. 12.2 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Type (2027-2032)
  5. 12.3 SAMEA Fungal Drugs for Treatment of Tinea Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Application (2027-2032)
  9. 12.5 SAMEA Fungal Drugs for Treatment of Tinea Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country
  11. 12.6.1 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Fungal Drugs for Treatment of Tinea Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst